Government is reviewing whether to proceed with the planned rollout of Oxford-AstraZeneca vaccine after a research showed it offered minimal protection against mild infection from a new variant spreading in the country from South Africa blamed for the surge in cases. South Africa announced on Monday its pause after researchers from the University of Witwatersrand […]